Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -7.72 |
| peg ratio | -0.84 |
| price to book ratio | 3.82 |
| price to sales ratio | 20.63 |
| enterprise value multiple | -10.38 |
| price fair value | 3.82 |
profitability ratios | |
|---|---|
| gross profit margin | 90.58% |
| operating profit margin | -230.12% |
| pretax profit margin | -284.02% |
| net profit margin | -284.02% |
| return on assets | -35.55% |
| return on equity | -56.75% |
| return on capital employed | -31.11% |
liquidity ratio | |
|---|---|
| current ratio | 13.01 |
| quick ratio | 12.94 |
| cash ratio | 11.75 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 151.82 |
| operating cycle | 331.61 |
| days of payables outstanding | 252.57 |
| cash conversion cycle | 79.03 |
| receivables turnover | 2.03 |
| payables turnover | 1.45 |
| inventory turnover | 2.40 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 0.21 |
| long term debt to capitalization | 0.16 |
| total debt to capitalization | 0.18 |
| interest coverage | -9.66 |
| cash flow to debt ratio | -1.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.68 |
| cash per share | 2.56 |
| operating cash flow per share | -0.67 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.50 |
| short term coverage ratios | -65.53 |
| capital expenditure coverage ratio | -72.83 |
Frequently Asked Questions
Ocular Therapeutix, Inc. (OCUL) published its most recent earnings results on 14-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ocular Therapeutix, Inc. (NASDAQ:OCUL)'s trailing twelve months ROE is -56.75%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ocular Therapeutix, Inc. (OCUL) currently has a ROA of -35.55%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
OCUL reported a profit margin of -284.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 13.01 in the most recent quarter. The quick ratio stood at 12.94, with a Debt/Eq ratio of 0.21.